Skip to content

Pre-Tax Income at other companies

ALN
Alnylam PharmaceuticalsALNY
$221.65M+9,460%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$8.3M+61.4%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-$9.24M-299%
Opko Health logo
Opko HealthOPK
-$60.96M+16.9%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$76.14M+8.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$11.66M+1.3%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Tectonic Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's pre-tax income?
Tectonic Therapeutics (TECX) reported pre-tax income of -$18.97M in Q4 2025.
How has Tectonic Therapeutics's pre-tax income changed year-over-year?
Tectonic Therapeutics's pre-tax income decreased by 53.3% year-over-year, from -$12.37M to -$18.97M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.